⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16141767 | 1.00 | — | — | |
| SCHEMBL12734368 | 1.00 | — | — | |
| SCHEMBL18513690 | 0.86 | — | — | |
| SCHEMBL18513576 | 0.86 | — | — | |
| SCHEMBL5986536 | 0.86 | — | — | |
| SCHEMBL2092701 | 0.85 | — | — | |
| SCHEMBL21786325 | 0.82 | — | — | |
| SCHEMBL21401226 | 0.82 | — | — | |
| SCHEMBL17931427 | 0.82 | — | — | |
| SCHEMBL19236669 | 0.80 | TSHR (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109075394-B | Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same | 株式会社LG化学 | 2021-08-27 | — | — | CN | claimed |
| EP-3429020-B1 | ELECTROLYTE FOR LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG CHEMICAL LTD (KR) | 2021-08-18 | — | — | EP | claimed |
| CN-108292782-B | Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same | 株式会社LG化学 | 2021-05-11 | — | — | CN | claimed |
| US-10930975-B2 | Electrolyte for lithium-sulfur battery and lithium-sulfur battery comprising same | LG CHEM, LTD. (KR) | 2021-02-23 | — | — | US | claimed |
| US-10629946-B2 | Electrolyte for lithium-sulfur battery, and lithium-sulfur battery comprising same | LG CHEM, LTD. (KR) | 2020-04-21 | — | — | US | claimed |
| CN-107254042-B | Synthetic method of unsaturated polyoxyethylene ether containing oxa- cycloalkane and products thereof and application | 上海台界化工有限公司 | 2019-04-02 | — | — | CN | claimed |
| US-20190097270-A1 | ELECTROLYTE FOR LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-03-28 | — | — | US | claimed |
| EP-3429020-A1 | ELECTROLYTE FOR LITHIUM-SULFUR BATTERY AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG Chem, Ltd. (KR) | 2019-01-16 | — | — | EP | claimed |
| US-20180301739-A1 | ELECTROLYTE FOR LITHIUM-SULFUR BATTERY, AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-10-18 | — | — | US | claimed |
| EP-3355401-A1 | ELECTROLYTE FOR LITHIUM-SULFUR BATTERY, AND LITHIUM-SULFUR BATTERY COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-08-01 | — | — | EP | claimed |
| CN-113929612-B | Preparation method of etodolac intermediate | 鲁南制药集团股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-113929612-B | Preparation method of etodolac intermediate | 鲁南制药集团股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-113666860-B | Preparation method of 7-ethyl tryptol | 鲁南制药集团股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| WO-2023220046-A1 | TYK2 INHIBITORS | BIOGEN MA INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-115504923-A | Preparation method of 7-ethyl tryptophol | 山东新时代药业有限公司 | 2022-12-23 | — | — | CN | disclosed |
| US-7265230-B2 | For inhibiting undesirable plant growth | SYNGENTA PARTICIPATIONS AG (CH) | 2007-09-04 | — | — | US | disclosed |
| US-7265230-B2 | For inhibiting undesirable plant growth | SYNGENTA PARTICIPATIONS AG (CH) | 2007-09-04 | — | — | US | disclosed |
| US-20070105781-A1 | Inhibitors of serine proteases | VERTEX PHARMACEUTICALS INCORPORATED | 2007-05-10 | — | — | US | disclosed |
| US-20070072803-A1 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | ARENA PHARMACEUTICALS (US) | 2007-03-29 | — | — | US | disclosed |
| US-6329400-B1 | INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS | GLAXO WELLCOME INC. | 2001-12-11 | — | — | US | disclosed |